Efficacy of PRGF Supplementation After TMJ Arthrocentesis in Patients With TMJ Osteoarthritis
A Randomized, Double-Blind Study of the Efficacy of Platelet-Rich Growth Factor (PRGF) Supplementation Compared to Steroid Supplementation After Temporomandibular Joint (TMJ) Arthrocentesis in Female Patients With TMJ Osteoarthritis (OA)
Sponsor: University of Florida
Terminated
Could not recruit participants due to their refusal to be randomized in the study.
Other terminated trials from University of Florida
Other Osteoarthritis trials with similar outcome
Listed as NCT04731233, this PHASE4 trial focuses on Osteoarthritis and TMJ and remains terminated or withdrawn. Sponsored by University of Florida, it has been updated 10 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Mar 2025 — Present [monthly]
Terminated PHASE4
-
Feb 2025 — Mar 2025 [monthly]
Terminated PHASE4
Status: Active Not Recruiting → Terminated
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Jun 2023 — Mar 2024 [monthly]
Recruiting PHASE4
-
Feb 2023 — Jun 2023 [monthly]
Recruiting PHASE4
-
Feb 2022 — Feb 2023 [monthly]
Recruiting PHASE4
-
May 2021 — Feb 2022 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — May 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Florida
For direct contact, visit the study record on ClinicalTrials.gov .